financetom
Business
financetom
/
Business
/
Seagate Technology Holdings Insider Sold Shares Worth $1,135,559, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Seagate Technology Holdings Insider Sold Shares Worth $1,135,559, According to a Recent SEC Filing
May 26, 2025 1:37 PM

04:09 PM EDT, 05/23/2025 (MT Newswires) -- Judy Bruner, Director, on May 22, 2025, sold 10,446 shares in Seagate Technology Holdings ( STX ) for $1,135,559. Following the Form 4 filing with the SEC, Bruner has control over a total of 12,268 common shares of the company, with 12,268 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1137789/000113778925000090/xslF345X05/wk-form4_1748030587.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan
Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan
Jun 12, 2024
04:54 AM EDT, 06/12/2024 (MT Newswires) -- Belite Bio ( BLTE ) said Wednesday its oral tablet tinlarebant for the treatment of Stargardt disease has secured Sakigake, or pioneer drug designation, by the Ministry of Health, Labor and Welfare in Japan. Sakigake designation is intended to accelerate the drug approval process in Japan for innovative drugs with prominent effectiveness targeting...
Ultragenyx, Mereo BioPharma Say Phase 2 Study of Bone Disorder Drug Showed Reduced Fracture Rate
Ultragenyx, Mereo BioPharma Say Phase 2 Study of Bone Disorder Drug Showed Reduced Fracture Rate
Jun 12, 2024
04:44 AM EDT, 06/12/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) and Mereo BioPharma Group ( MREO ) said late Tuesday a phase 2 study of setrusumab showed ongoing and meaningful improvements in the lumbar spine bone mineral density of patients with osteogenesis imperfecta. The drug companies said the phase 2 portion of an ongoing phase 2/3 study showed...
Update: Oracle Fiscal Q4 Non-GAAP Earnings Fall, Sales Rise; Unveils Microsoft, Google Partnerships; Shares Gain Premarket
Update: Oracle Fiscal Q4 Non-GAAP Earnings Fall, Sales Rise; Unveils Microsoft, Google Partnerships; Shares Gain Premarket
Jun 12, 2024
04:57 AM EDT, 06/12/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Oracle (ORCL) shares were up 9% in premarket activity Wednesday after the company reported overnight an increase in fiscal Q4 sales and unveiled partnerships with Microsoft ( MSFT ) and Alphabet's (GOOG, GOOGL) Google ( GOOG ). The company reported fiscal...
Singapore's top bank DBS eyes $370 billion in wealth assets by 2026, top exec says
Singapore's top bank DBS eyes $370 billion in wealth assets by 2026, top exec says
Jun 12, 2024
By Yantoultra Ngui SINGAPORE (Reuters) - DBS Group plans to boost assets under management for its wealth business to S$500 billion ($369.7 billion) by the end of 2026, said the unit's head, as the top Singaporean bank bets on robust inflows into the city state. Wealth assets at DBS grew 23% to a record S$365 billion last year, as Singapore...
Copyright 2023-2026 - www.financetom.com All Rights Reserved